Should You Buy Jade Biosciences Inc (JBIO) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast JBIO stock price to rise
5 Analyst Rating
Wall Street analysts forecast JBIO stock price to rise
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 20.840
Low
17
Averages
23.75
High
28
Current: 20.840
Low
17
Averages
23.75
High
28
Guggenheim
NULL
to
Buy
maintain
$23 -> $32
AI Analysis
2026-05-11
Reason
Guggenheim
Price Target
$23 -> $32
AI Analysis
2026-05-11
maintain
NULL
to
Buy
Reason
Guggenheim raised the firm's price target on Jade Biosciences to $32 from $23 and keeps a Buy rating on the shares. Following the Q1 update, the firm is revising its detailed IgAN market model, the analyst tells investors.
Wedbush
Laura Chico
Outperform
maintain
$24 -> $34
2026-05-11
Reason
Wedbush
Laura Chico
Price Target
$24 -> $34
2026-05-11
maintain
Outperform
Reason
Wedbush analyst Laura Chico raised the firm's price target on Jade Biosciences to $34 from $24 and keeps an Outperform rating on the shares. Preliminary Phase 1 JADE101 data will be presented at the ERA Congress. The firm's base case assumes JADE101 demonstrates IgA reductions at least on par with sibeprenlimab. Wedbush sees about 20% upside from current levels with this profile. The firm sees downside risk to the mid-teens on a complete miss, but upside to the high-30s can be unlocked with better-than-anticipated IgA reductions and/or longer dosing intervals.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for JBIO
